Usefulness of thyrotropin-releasing hormone test, SMS 201–995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas
暂无分享,去创建一个
N. Dávila | P. Serrano | T. Lúcas | B. Barceló | J. Estrada | J. Alcañiz | C. Blanco
[1] I. Kourides,et al. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). , 1992, The Journal of clinical endocrinology and metabolism.
[2] E. Ridgway,et al. Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. , 1992, The Journal of clinical endocrinology and metabolism.
[3] A. Klibanski,et al. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. , 1991, The Journal of clinical endocrinology and metabolism.
[4] K. Lillehei,et al. Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. , 1991, The Journal of clinical endocrinology and metabolism.
[5] A. Klibanski,et al. Diagnosis and management of hormone-secreting pituitary adenomas. , 1991, The New England journal of medicine.
[6] P. Snyder,et al. Recognition of Gonadotroph Adenomas in Women , 1991, The New England journal of medicine.
[7] M. Molitch. Gonadotroph-cell pituitary adenomas. , 1991, The New England journal of medicine.
[8] A. Hsueh,et al. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone. , 1990, The Journal of clinical endocrinology and metabolism.
[9] A. Murdoch,et al. LH AND FSH SECRETION AND RESPONSES TO GnRH AND TRH IN PATIENTS WITH CLINICALLY FUNCTIONLESS PITUITARY ADENOMAS , 1990, Clinical endocrinology.
[10] S. Lamberts,et al. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. , 1989, The Journal of clinical endocrinology and metabolism.
[11] A. Klibanski,et al. Medical therapy of glycoprotein hormone-secreting pituitary tumors. , 1989, Endocrinology and metabolism clinics of North America.
[12] J. Thijssen,et al. Response of luteinizing hormone secreting pituitary adenoma to a long-acting somatostatin analogue. , 1988, Acta endocrinologica.
[13] F. Takaku,et al. Secretion of Glycoprotein Hormone α-Subunit by Pituitary Tumors* , 1987 .
[14] P. Black,et al. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. , 1987, The Journal of clinical endocrinology and metabolism.
[15] S. Lamberts,et al. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. , 1987, The Journal of clinical endocrinology and metabolism.
[16] P. Black,et al. Hormone production in clinically nonfunctioning pituitary adenomas. , 1987, Journal of neurosurgery.
[17] K. Kitamura,et al. The Significance of α-Subunit as a Tumor Marker for Gonadotropin-Producing Pituitary Adenomas∗ , 1986 .
[18] P. Snyder. Gonadotroph cell adenomas of the pituitary. , 1985, Endocrine reviews.
[19] G. Giannattasio,et al. Glycoprotein Hormone α-Subunit Response to Growth Hormone(GH)-Releasing Hormone in Patients with Active Acromegaly · Evidence for α-Subunit and GH Coexistence in the Same Tumoral Cell* , 1985 .
[20] M. Vance,et al. Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine. , 1985, The Journal of clinical endocrinology and metabolism.
[21] A. Beckers,et al. Follicle-stimulating hormone-secreting pituitary adenomas. , 1985, The Journal of clinical endocrinology and metabolism.
[22] K. Kovacs,et al. Gonadotroph adenomas of the human pituitary: sex-related fine-structural dichotomy. A histologic, immunocytochemical, and electron-microscopic study of 30 tumors. , 1984, The American journal of pathology.
[23] B. Lunenfeld,et al. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine. , 1984, The Journal of clinical endocrinology and metabolism.
[24] A. J. Chapman,et al. DISCORDANT SERUM α‐SUBUNIT AND FSH CONCENTRATIONS IN A WOMAN WITH A PITUITARY TUMOUR , 1984, Clinical endocrinology.
[25] W. Cobbs,et al. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery. , 1983, The Journal of clinical endocrinology and metabolism.
[26] S. Shalet,et al. Glycoprotein hormone alpha-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptine. , 1982, Acta endocrinologica.
[27] P. Snyder,et al. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. , 1980, The Journal of clinical endocrinology and metabolism.